Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
A phase I study of 5-fluorouracil, leucovorin and levamisole
J F Cleary, R Arzoomanian, D Alberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival
J H Schiller, B Storer, J Berlin, et al.
The British Journal of Nutrition
|
May 1, 1991
Effects of solvent extraction on the hypocholesterolaemic action of oat bran in the rat
R J Illman, D L Topping, K Dowling, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
May 9, 2015
Using Arden Syntax to identify registry-eligible very low birth weight neonates from the Electronic Health Record
Indra Neil Sarkar, Elizabeth S Chen, Paul T Rosenau, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC)
P M Sondel, J A Hank, N Rosenthal, et al.
Radiation Research
|
October 1, 1976
The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation
R L Ullrich, M C Jernigan, G E Cosgrove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial
S P Tannehill, M P Mehta, M Larson, et al.
Journal of the National Cancer Institute
|
March 2, 1988
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity
J A Sosman, P C Kohler, J Hank, et al.
Cancer Investigation
|
January 1, 1989
Phase 1 clinical trial of recombinant interleukin-2: a comparison of bolus and continuous intravenous infusion
P C Kohler, J A Hank, K H Moore, et al.
The British Journal of Nutrition
|
September 1, 1979
Effects of saponins on bile acids and plasma lipids in the rat
D G Oakenfull, D E Fenwick, R L Hood, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
A phase I study of 5-fluorouracil, leucovorin and levamisole
J F Cleary, R Arzoomanian, D Alberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival
J H Schiller, B Storer, J Berlin, et al.
The British Journal of Nutrition
|
May 1, 1991
Effects of solvent extraction on the hypocholesterolaemic action of oat bran in the rat
R J Illman, D L Topping, K Dowling, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
May 9, 2015
Using Arden Syntax to identify registry-eligible very low birth weight neonates from the Electronic Health Record
Indra Neil Sarkar, Elizabeth S Chen, Paul T Rosenau, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC)
P M Sondel, J A Hank, N Rosenthal, et al.
Radiation Research
|
October 1, 1976
The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation
R L Ullrich, M C Jernigan, G E Cosgrove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial
S P Tannehill, M P Mehta, M Larson, et al.
Journal of the National Cancer Institute
|
March 2, 1988
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity
J A Sosman, P C Kohler, J Hank, et al.
Cancer Investigation
|
January 1, 1989
Phase 1 clinical trial of recombinant interleukin-2: a comparison of bolus and continuous intravenous infusion
P C Kohler, J A Hank, K H Moore, et al.
The British Journal of Nutrition
|
September 1, 1979
Effects of saponins on bile acids and plasma lipids in the rat
D G Oakenfull, D E Fenwick, R L Hood, et al.
Page
of 13